Andy Allen

Director of Therapeutic Pipeline Programs

Dr Andy Allen has academic, small biotech, and large pharmaceutical company experience spanning over 20 years, in both the UK and Australia.

Andy completed his undergraduate and postgraduate studies at the University of Southampton and Cambridge University, respectively. As an academic researcher Andy studied protein chemistry and bacterial pathogenesis and utilized these skills working as a project leader for 10 years at Pfizer Animal Health and Zoetis developing vaccines for animals.

Andy also has extensive experience in identifying opportunities for development and commercialisation and more recently supporting the translation of academic research at the University of Melbourne.